Results 251 to 260 of about 454,859 (358)

Glycogen synthase activity in <i>Candida albicans</i> is partly controlled by the functional ortholog of <i>Saccharomyces cerevisiae</i> Gac1p. [PDF]

mSphere
Miao J, Williams DL, Kruppa MD, Peters BM.   +3 more
europepmc   +1 more source

Large Scale Protein Production and Activity Assay Protocols for Human Glycogen Synthase-Glycogenin Complex

, 2023
Marr L, Biswas D, Sakamoto K, Zeqiraj E.
europepmc   +1 more source

Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.

ACS Chemical Neuroscience, 2012
J. Morales-García, Rosario Luna-Medina, S. Alonso-Gil, M. Sanz-Sancristobal, V. Palomo, C. Gil, Ángel Santos, Ana Martínez, A. Pérez-Castillo   +8 more
semanticscholar   +1 more source

Fetal glucose availability: a key regulator of the metabolic, hormonal and contractility profiles of the fetal sheep heart

The Journal of Physiology, EarlyView.
Abstract figure legend To investigate the role of glucose availability in fetal left ventricle (LV) development, this study assessed whether maternal late gestation undernutrition (LGUN; 50% of Control diet) induced alterations in the contractility, metabolic, and hormonal profile can be ameliorated in LGUN fetuses receiving glucose infusion (LGUN+G ...
Melanie R. Bertossa, Jack R. T. Darby, Stacey L. Holman, Steven K. S. Cho, Ashley S. Meakin, Mitchell C. Lock, Jordan A. Minns, Michael D. Wiese, Christopher K. Macgowan, Mike Seed, Janna L. Morrison   +10 more
wiley   +1 more source

Inhibiting glycogen synthase kinase 3 suppresses TDP-43-mediated neurotoxicity in a caspase-dependent manner

White MA, Crowley L, Massenzio F, Li X, Niblock M, Coleman MP, Barmada SJ, Sreedha J.   +7 more
europepmc   +1 more source

Expanding therapeutic options for Pompe disease: a new small molecule inhibitor of glycogen synthase 1 (GYS1) shows preclinical promise in Pompe disease. [PDF]

Ann Transl Med
Koch RL, Cocanougher BT, Lim JA, Raben N, Kishnani PS.   +4 more
europepmc   +1 more source

14‐3‐3 proteins: Regulators of cardiac excitation–contraction coupling and stress responses

The Journal of Physiology, EarlyView.
Abstract figure legend 14‐3‐3 protein interactions in cardiac regulation. Schematic representation of 14‐3‐3 binding partners in excitation–contraction coupling, transcriptional regulation/development and stress response pathways. Asterisks indicate targets where the exact 14‐3‐3 binding site is unknown.
Heather C. Spooner, Rose E. Dixon
wiley   +1 more source

Glycogen synthase kinase and Dictyostelium development: old pathways pointing in new directions?

, 1995
Robert H. Insall
openalex   +1 more source

Antioxidant supplementation blunts the proteome response to 3 weeks of sprint interval training preferentially in human type 2 muscle fibres

The Journal of Physiology, EarlyView.
Abstract figure legend Sprint interval training (SIT) is a popular time‐efficient type of endurance training. Healthy young men performed nine SIT sessions (4–6 × 30 s all‐out cycling sprints) over 3 weeks while being supplemented with antioxidants (high doses of vitamins C and E) or placebo. Muscle biopsies taken before and after the first SIT session
Victoria L. Wyckelsma, Marta Murgia, Sigitas Kamandulis, Stefano Gastaldello, Marius Brazaitis, Audrius Snieckus, Nerijus Eimantas, Mati Pääsuke, Sebastian Edman, William Apro, Daniel C. Andersson, Håkan Westerblad, Tomas Venckunas   +12 more
wiley   +1 more source

Glycogen synthase kinase-3 inhibition and insulin enhance proliferation and inhibit maturation of human iPSC-derived cardiomyocytes via TCF and FOXO signaling. [PDF]

Stem Cell Reports
Yuan Q, Verbueken D, Dinani R, Kim R, Schoger E, Morsink CD, Simkooei SA, Kemna LJM, Hjortnaes J, Kuster DWD, Boon RA, Zelarayan LC, van der Velden J, Buikema JW.   +13 more
europepmc   +1 more source